Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06726915

Effect of Different Maternal Hemoglobin and Hematocrit Values on Perinatal Outcome

This study aims to evaluate the perinatal outcome in pregnancies with different levels of hemoglobin/hematocrit to verify which category of women should have iron supplementation if not all.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

About this study

Anaemia in pregnant women has been reported to have various adverse effects on both the mother and unborn foetus. These effects include preterm birth, a low birth weight and an increase in the risk of maternal and perinatal mortality . Postpartum anaemia impairs wound healing, increases the risk for readmission and/or prolonged hospitalization, and increases the cost of care for families .

Some investigators stated adverse perinatal outcome in pregnant mothers with high haemoglobin and haematocrit values and raised a question about the possible harmful effect of iron supplementation in such pregnancies.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Pregnant women scheduled for labor or C.S (at term, 28-42 weeks). 3. Singleton pregnancy. 4. Age range: 18-40 years. 5. Willing to provide informed consent for participation and follow-up.

Exclusion criteria

  • Refusal to participate or consent.
  • Presence of non-iron deficiency anemia (e.g., hemoglobinopathies, chronic disease-related anemia).
  • Multiple pregnancies (e.g., twins or more).
  • Antepartum hemorrhage (e.g., placenta previa, placental abruption).
  • PAS.
  • Malformed fetus. -

Treatment and study plan

Primary outcomes

  1. Fetal weight measurement- still birth or major morbidity

    Time frame: Baseline

Secondary outcomes

  1. Maternal needs for iron therapy

    Time frame: Baseline

  2. . Un-even postpartum period: Failure of lactation- DVT- CS wound complications Postpartum anaemia

    Time frame: Baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Ali Mohamed Ammar, Graduate

CONTACT

[email protected]

0201032760152

Hassan Salah Kamel

CONTACT

[email protected]

+20 1006664910

Sponsors and collaborators

Lead sponsor

Ali Mohamed Mohamed Ammar

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 10, 2024
Registry last updated
Dec 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.